Hepatitis C Drugs Show Patients Benefit Most From Treatment Choices
Wednesday, January 14, 2015 - 16:21
in Health & Medicine
By Josh Bloom and Henry MillerThe development of new drugs is among the riskiest of business ventures. It now takes 10-15 years for a pharmaceutical company to get a new drug approved, and on average the cost exceeds $2.5 billion. To establish its safety and effectiveness, a candidate drug or vaccine undergoes a lengthy process of laboratory, animal and clinical studies, and then regulatory review is conducted by the highly risk-averse FDA. read more